
BIOCLIN PHYDRIUM ADVANCE is a new line of product that combines the proprietary and innovative natural-based complex, STIMOXIDIL® which have been clinically shown to reduce hair loss by increasing hair resistance and thickness resulting in stronger and healthier hair.
BIOCLIN PHYDRIUM ADVANCE AMPOULES FOR WOMEN is specifically formulated with ingredients to fortify, nourish and revitalize the scalp and provide anti-oxidant activities and regenerating actions to the hair follicle leading to strengthen thinning and weak hair.
Bioclin Advance contains additional botanical ingredients that help to reduce DHT hormonal damage to the scalp and increases the scalp’s microcirculation favoring healthy hair growth. In addition, the product contains the full range of B vitamins (B3, B5, B6, B7) known to support hair health.
For best results, combine Ampoules use with BIOCLIN PHYDRIUM ADVANCE SHAMPOO.
A clinical study (detailed below) on individuals (male and female) showed statistically significant improvements without any adverse events by 30 days using Bioclin Ampoules and Shampoo in the following parameters:
CONTENTS:
Contains 15 ampoules with 5ml/ampoule, appropriate for a month’s supply.
CHARACTERISITICS OF BIOCLIN PHYDRIUM ADVANCE
KEY INGREDIENTS
STIMOXIDIL® is a new proprietary formulation consisting of innovative evidence-based biological compounds coupled with selected botanical ingredients based on demonstrated hair health.
![]() |
Potassium CLA Glutathione
Glutathione is a tripeptide that is synthesized in the liver and performs a cell protective function in all animals due its activity as an anti-oxidant actions to reduce oxidative stress and detoxifying agent.
Sodium DNA - Acts to nourish and stimulate the regeneration of that tissues surround the hair follicles.
CLINICAL STUDY
(Rigano, et al., CLA Glutathione and Sodium DNA for reducing hair loss. Cosmetic & Toiletries Magazine. 2007. 71-80)
BOTANICAL EXTRACTS
B VITAMINS
BIOCLIN PHYDRIUM ADVANCE CLINICAL STUDY
A Study Was Conduct To Assess The Efficacy, Tolerability And Safety Of Bioclin Phydrium Advance In Volunteers (Male, Female) With Androgenetic Alopecia During A 60 Days Period.
With regards to tolerability and safety, skin test was conducted and no adverse event was observed during the study period with use of Bioclin Phydrium Advance. This was determined by both clinical assessments of the scalp/hair and based on each participant feedback on the safety of the product.
Assessment of product efficacy was evaluated by Phototrichogram to calculate the total number of hair, number of anagen (new hair) and telogen (hair loss). For analysis of hair resistance, a pull-test was conducted. In the determination of increase hair diameter, hairs were cut and analyzed with a Microcamera Dermotricos.
The results as per Figure 1, demonstrated that Bioclin Advance produced statistically significant improvement in individuals after one month of usage with further improvement at two months.
In all of the measures, including growth of new hair, reduction of hair loss, increased hair resistance and increased hair thickness, Bioclin Phydrium Advance demonstrated significant improvement. Within the men subpopulation, an average of 90% demonstrated improvement in new hair, hair loss, hair resistance and hair thickness.
FIGURE 1
|
FIGURE 2.
|
A subjective analysis was conducted to assess each of the participant assessment of the relative benefit of the product by providing a questionnaire with a listed of questions. Evaluation was based on the relative score of each question to calculate the percentage of satisfied subjects. Figure 2 demonstrated that at the 30 days assessment point, at least 50% or more individuals were satisfied with the product performance based on reducing hair loss, regrowth of new hair, increase hair thickness, faster regrow and making hair stronger. These results improved further at the 60 days review period, with the exception of quicker hair regrowth.
BIOCLIN PHYDRIUM ADVANCE REFERENCES: